Title:
Medical use of illicit drugs / Kathleen Cronin, book editor.
Author:
Cronin, Kathleen M., editor.
Publication Information:
New York : Greenhaven Publishing, 2020.
Call Number:
RM324.8 .M43 2020
Abstract:
"With the legalization of medical marijuana becoming increasingly common in many states, the medicinal potential of formerly illicit drugs has caught the public's attention. However, marijuana is not the only drug being researched and used medicinally: MDMA, psilocybin, and ketamine have been found to have therapeutic qualities, which leads some to question whether the medical use of these substances may also be legal in the future. This volume explores issues like regulation, the ethics of using illicit drugs in medical and scientific research, and its place in the greater history of drug regulation in the United States"-- Provided by publisher.
Edition:
First edition.
ISBN:
9781534506114
9781534506107
Series:
Current controversies
Current controversies.
Physical Description:
200 pages ; 23 cm.
Subject Term:
Contents:
Does medical research with illicit drugs benefit patients? Overview: Studies document potential medicinal effects of illicit substances, but questions remain / Monica Dybuncio and Ryan Jaslow -- The possibilities for innovative medical treatments are unlimited / Phillip Francis -- Drugs from the 1960s are the focus of new research / Denis Campbell -- Creating contemporary criteria for drug evaluation and policies / Veljko Dubljević -- Challenges with medical tourism / Jennifer Whitlock -- Is the current drug approval and regulation process the best option for patients? Overview: A century of regulated drug development has improved health outcomes and created guidelines for innovation and new therapies / US Food and Drug Administration -- The 2018 FDA approvals benefit patients / Monique Ellis -- The medical impact of recent advances in technology / Monique Ellis -- Stem cells have changed everything, but stem cell research was hindered by research bans / Michael White -- The drug approval process is confusing / Comment Central -- Government regulation adds costs and red tape, weighing down scientific innovation / Dean Baker -- Does current regulation of illicit drugs inhibit medical innovation? Overview: Research in drug innovation may not be aimed in the right direction / Christopher-Paul Milne and Kenneth J. Kaitin -- Illegal drugs will be a catalyst for dramatic scientific innovation / David Nutt -- We need to study and collect data on medical marijuana / David Trilling -- Removing long-time barriers to research and medical innovation / David Nutt -- Science defines medical cannabis today / Dr. C.M. Helm-Clark -- Historically, medical experiments led to accidental addiction / Stevyn Colgan -- Should the medical use of illicit drugs be exempt from legal repercussions? Overview: Questions for consideration in developing drug policy / Mark A.R. Kleiman, Jonathan P. Caulkins, Angela Hawken, and Beau Kilmer -- Can Employees smoke marijuana on the job? / The Emplawyerologist Firm -- Legalizing cannabis could have positive benefits / Teri Moore -- Misuse and abuse of legal stimulants requires analysis and new policy / Steve Sussman, Mary Ann Pentz, Donna Spruijt-Metz, and Toby Miller -- Psychoactive substances available in cyberspace cause harm / Eduardo Cinosi [and six others].
Added Author:
Reading Level:
Grades 9-12.
Subject:
